The Karnataka High Court has provided temporary relief to pharmaceutical companies by directing the government not to act against firms producing nutraceuticals in drug-licensed units until the next hearing. This follows the industry's challenge to Schedule M, which prohibits manufacturing non-drug products in drug facilities.
